Norwegen - Norwegisch - Statens legemiddelverk

glaxosmithkline as - flutikasonpropionat - nesespray, suspensjon - 50 mikrog/ dose

Norwegen - Norwegisch - Statens legemiddelverk

glaxosmithkline as - flutikasonpropionat - nesedråper, suspensjon - 1 mg/ ml

Norwegen - Norwegisch - Statens legemiddelverk

glaxosmithkline as - flutikasonpropionat - krem - 0.05 %

Norwegen - Norwegisch - Statens legemiddelverk

glaxosmithkline as - flutikasonpropionat - salve - 0.005 %

Norwegen - Norwegisch - Statens legemiddelverk

n.v. organon - kloosterstraat - mometasonfuroat - inhalasjonspulver - 200 mikrog

Norwegen - Norwegisch - Statens legemiddelverk

n.v. organon - kloosterstraat - mometasonfuroat - inhalasjonspulver - 400 mikrog

Europäische Union - Norwegisch - EMA (European Medicines Agency)

teva b.v. - fluticasone propionate, salmeterol xinafoate - astma - legemidler for obstruktive sykdommer i luftveiene, - seffalair spiromax is indicated in the regular treatment of asthma in adults and adolescents aged 12 years and older not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short-acting β₂ agonists.

Norwegen - Norwegisch - Statens legemiddelverk

2care4 - flutikasonpropionat / formoterolfumaratdihydrat - inhalasjonsaerosol, suspensjon - 125 mikrog/ dose / 5 mikrog/ dose

Norwegen - Norwegisch - Statens legemiddelverk

2care4 - flutikasonpropionat / formoterolfumaratdihydrat - inhalasjonsaerosol, suspensjon - 125 mikrog/ dose / 5 mikrog/ dose

Norwegen - Norwegisch - Statens legemiddelverk

orifarm as - flutikasonpropionat - inhalasjonsaerosol, suspensjon - 50 mikrog/ dose